Navigation Links
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
Date:11/1/2010

SEATTLE, Nov. 1, 2010 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it has submitted a Marketing Authorization Application ("MAA") to the European Medicines Agency ("EMA") for Pixuvri® (pixantrone dimaleate) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL"). The application submission follows a positive opinion from the EMA's Pediatric Committee (the "PDCO"), where PDCO agreed to CTI's Pediatric Investigation Plan ("PIP") for Pixuvri.

"This is an important milestone for CTI, and underscores our commitment to making pixantrone available to patients who currently have no approved or effective therapies for this life threatening disease," said James A. Bianco, M.D., CEO of CTI. "We appreciate the efforts of all the people who made the MAA submission possible, especially the investigators and patients who participated in our clinical trial."  

"PIX301 was not only the first and only randomized trial in this patient population, it was also the largest study ever conducted for patients with multiply relapsed and refractory aggressive NHL. The positive results of this trial are among the most effective ever reported in this group of patients," noted Ruth Pettengell, M.D., of St. George's Hospital, University of London, the principal investigator on the study. "The robustness of the drug's effect in prolonging progression free survival irrespective of risk factors lends to the strength and credibility of the clinical benefit provided to patients in the trial. Currently there are no approved drugs available to patients today as such pixantrone will be a valuable new addition to offer these patients a new hope for controlling their disease."

Pixantrone was granted orphan drug status by the EMA for the treatment of diffuse large B-cell lymphoma (DLBCL). CTI expects that the EMA will make a determination regarding the ac
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... PARSIPPANY, N.J. , July 30, 2015  Growth ... Rx-to-OTC switches as they bring former prescription users to ... environment, Kline forecasts robust Rx-to-OTC switch activity ... OTC categories emerging along with many new brands entering ... switches occur over the next five years (even those ...
(Date:7/30/2015)... 30, 2015   Gaumard® Scientific Company ... the world,s first operating system to support an ... exclusively to Gaumard users. UNI® version 2.27.21.0 adds ... Tory™ S2200, as well as improvements to laboratory ... measures such as EtCO 2 .  ...
(Date:7/30/2015)... -- What can be expected from the ... to grow at the fastest rates? Visiongain ,s ... assessing data, trends, opportunities and prospects there. ... and graphs. Discover the most lucrative areas in the ... lets you assess forecasted sales at overall world market ...
Breaking Medicine Technology:Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... leading international scientist in the field of infection control ... potential for cross-contamination in the dental office, specifically from ... in place. (Photo: http://photos.prnewswire.com/prnh/20110725/CL40171 ) ... Infection Control for The Dental Advisor , Ann ...
... 25, 2011 JHP Pharmaceuticals, a leading provider of ... into an agreement with an undisclosed biotech company to ... in the treatment of heart failure. ... are pleased that JHP was chosen to produce clinical ...
Cached Medicine Technology:Question Your Dentist About Potential for Cross-Contamination, Leading Infection-Control Scientist Tells Fox News 2JHP Pharmaceuticals to Produce Clinical Batches of Innovative Cardiac Drug 2
(Date:7/30/2015)... California (PRWEB) , ... July 30, 2015 , ... Dale ... the United States, will speak at the International Cannabis Professionals Expo held at the ... , The International Cannabis Professionals Expo is the largest medical cannabis ...
(Date:7/30/2015)... ... July 31, 2015 , ... The Venetian on Grace Bay in the Turks & ... stay at the Venetian will save 40% on their stay while enjoying some of the ... in the Turks & Caicos, providing a chance to reconnect with loved ones and rediscover ...
(Date:7/30/2015)... ... 2015 , ... Committed to helping the next generation succeed - Mercy College ... to the College’s “My Brother’s Keeper Scholarship.” The President’s signature initiative issues a call ... the support they need to think more broadly about their future. Building on what ...
(Date:7/30/2015)... ... 30, 2015 , ... As more hospitals across the country see the value ... serious challenge. Because of growing competition, it is more important than ever to ... , The team at Wound Care Advantage has found that while many ...
(Date:7/30/2015)... ... 30, 2015 , ... OSF Healthcare System has been recognized as ... Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive year for ... The Sisters of the Third Order of St. Francis . , Health data security ...
Breaking Medicine News(10 mins):Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... When we travel for sport -- whether to play it ... the place we visited to do that. Sport tourism is ... his youth. And, because it,s become a leisure phenomenon with ... all the more timely that Hinch and his New Zealand ...
... forms of dementia is crucial for initiating appropriate treatment. ... underlying diseases leave different "fingerprints" in the cerebrospinal fluid, ... two most common forms of dementia are Alzheimer,s disease ... circulation in the small blood vessels of the brain, ...
... difficulties to perform everyday activities. This is not primarily due ... as was previously believed new research from the University ... to initiate and complete a task towards a specific goal. ... which normally results in a degree of paralysis in the ...
... 4, 2011 Researchers at the Institut de recherches ... identified a new gene that modulates bone mass and ... This scientific breakthrough will be published tomorrow in the ... is a "silent" genetic disease characterized by low bone ...
... (Boston) - Researchers from Boston Medical Center (BMC) and ... among advanced head and neck cancer (HNC) patients receiving ... more significant predictor of treatment outcome than being of ... the 53rd annual American Society for Radiation Oncology (ASTRO) ...
... Vivien Chen, Professor of Public Health and Director of ... New Orleans, has been awarded a grant totaling $794,091 ... collect and report pediatric cancer cases at the local, ... and Prevention awarded the grant. LSUSHC,s Louisiana Tumor ...
Cached Medicine News:Health News:Sport tourism development book reveals new insights on growing leisure activity 2Health News:Sport tourism development book reveals new insights on growing leisure activity 3Health News:Biological fingerprints improve diagnosis of dementia 2Health News:Children with spina bifida need personal 'starter' 2Health News:An important breakthrough at the IRCM associated with osteoporosis 2Health News:Study finds non-English speaking head and neck cancer patients have significantly worse outcomes 2Health News:Grant to LSUHSC Tumor Registry creates pediatric cancer research tool 2
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
... iFacts™ is the handheld ... Facts, a drug interaction ... brand and generic drugs. ... to refer to accurate ...
... This comprehensive guide provides ... drug administration information in a ... revised 2006 edition includes the ... FDA with key nursing implications ...
Focuses primarily on the drugs used for treatment and symptom management for colorectal cancer....
Medicine Products: